ÂÜÀòÂÒÂ×

Ann Merrifield currently serves as board director for a portfolio of public and private companies in the life sciences sector which include Flexion Therapeutics, Inc., InVivo Therapeutics Holdings Corp., and Veritas Genetics Inc.

Previously, she spent an 18-year career at Genzyme Corporation, a diversified global biotechnology company. While at Genzyme, Ann served as President, Genzyme Biosurgery, where she led global business strategy and operations across a portfolio of biologics and therapeutic devices. She also served as President, Genzyme Genetics, playing a key role in developing this start-up genetic diagnostics business and bringing it to profitability.

Following Genzyme from 2012-2014, she served as President, Chief Executive Officer and director of PathoGenetix Inc., a genomics company. Ms. Merrifield holds a B.A. in Zoology and a Master of Education from the University of Maine and an M.B.A. from the Tuck School of Business at Dartmouth College.